Market Research Logo

US Market Report for Internal and External Radiation Therapy Devices - MedCore

Radiation therapy (RT) is a type of treatment most commonly used against cancer or to control and kill malignant cells. Typically, X-rays, gamma rays or charged particles (CPs) are the medium used. For oncological applications, RT works by attacking a cancerous cell’s DNA. DNA (deoxyribonucleic acid), the molecules inside a cell that contain and pass along genetic data, is used in the development and operation of all known living organisms and certain viruses. RT works by damaging the DNA of cancerous cells, which leads to an inability for the targeted cells to grow. RT may be administered as either an adjunct or primary treatment therapy.


EXECUTIVE SUMMARY FOR COMPLETE REPORT SUITE
1.1 MARKET OVERVIEW
1.2 COMPETITIVE LANDSCAPE
1.3 MARKET TRENDS
1.4 KEY MARKET DEVELOPMENTS
1.5 INCIDENCE RATES INCLUDED
1.6 PROCEDURE NUMBERS
1.7 MARKETS INCLUDED
1.8 KEY REPORT UPDATES
1.9 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
CANCER INCIDENCE RATES
3.1 INTRODUCTION
3.2 CANCER BY TYPE
3.2.1 Genital Cancer
3.2.2 Digestive Cancer
3.2.3 Respiratory Cancer
3.2.4 Breast Cancer
3.2.5 Urinary Cancer
3.2.6 Skin Cancer
3.2.7 Lymphoma
3.2.8 Endocrine System Cancer
3.2.9 Leukemia
3.2.10 Oral Cavity/Larynx
3.2.11 Myeloma
3.2.12 Brain/Other Nervous System
3.2.13 Soft Tissue (Non-Heart)
3.2.14 Bones and Joints
3.2.15 Eye and Orbit
EXTERNAL RADIATION THERAPY MARKET
4.1 INTRODUCTION
4.1.1 External Radiation
4.1.1.1 External Radiation Therapy Device Types
4.1.1.1.1 Cobalt-60 Machines
4.1.1.1.2 Linear Particle Accelerators
4.1.1.1.3 Proton Therapy Machines
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total External Radiation Therapy Device Market
4.3.1.1 Linear Accelerator Device Market
4.3.1.2 Proton Therapy Device Market
4.3.2 Total External Radiation Therapy Device Maintenance Revenue
4.3.2.1 Linear Accelerator Maintenance Revenue
4.3.2.2 Proton Therapy Device Maintenance Revenue
4.4 DRIVERS AND LIMITERS
4.4.1 Linear Accelerator Device Market
4.4.1.1 Market Drivers
4.4.1.2 Market Limiters
4.4.2 Proton Therapy Device Market
4.4.2.1 Market Drivers
4.4.2.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
4.5.1 Linear Accelerator Device Market
4.5.2 Proton Therapy Device Market
INTERNAL RADIATION THERAPY DEVICE MARKET
5.1 INTRODUCTION
5.1.1 Internal Radiation
5.1.1.1 Types of Internal Radiation Therapy
5.1.1.1.1 Permanent RTi
5.1.1.1.2 Temporary RTi
5.1.1.2 Dose Rate
5.1.1.2.1 Low-Dose Rate (LDR)
5.1.1.2.2 Medium-Dose Rate (MDR)
5.1.1.2.3 High-Dose Rate (HDR)
5.1.1.2.4 Pulsed-Dose Rate (PDR)
5.1.1.3 Types of Internal Radiation Therapy Sources
5.1.1.3.1 LDR Sources
5.1.1.3.2 HDR Sources
5.1.1.4 Afterloaders
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total HDR Brachytherapy Market
5.3.1.1 Afterloader Market
5.3.1.2 Afterloader Service Market
5.3.2 Total LDR Brachytherapy Market
5.3.2.1 Total LDR Seed Market
5.3.2.1.1 Total Cesium-131 Seed Market
5.3.2.1.2 Total Paladium-103 Seed Market
5.3.2.1.3 Total Iodine-125 Seed Market
5.3.2.2 LDR Needle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
List of Chart
Chart 1 1: Interventional Oncology Device Market by Segment, U.S., 2012 – 2022 (US$M) 2
Chart 1 2: Interventional Oncology Device Market Overview, U.S., 2015 & 2022 2
Chart 3 1: Male Incidence, Genital Cancer, U.S., 2014 32
Chart 3 2: Male Deaths, Genital Cancer, U.S., 2014 32
Chart 3 3: Female Incidence, Genital Cancer, U.S., 2014 33
Chart 3 4: Female Deaths, Genital Cancer, U.S., 2014 33
Chart 3 5: Male Incidence, Digestive Cancer, U.S., 2014 35
Chart 3 6: Male Deaths, Digestive Cancer, U.S., 2014 35
Chart 3 7: Female Incidence, Digestive Cancer, U.S., 2014 36
Chart 3 8: Female Deaths, Digestive Cancer, U.S., 2014 36
Chart 3 9: Male Incidence, Respiratory Cancer, U.S., 2014 38
Chart 3 10: Male Deaths, Respiratory Cancer, U.S., 2014 38
Chart 3 11: Female Incidence, Respiratory Cancer, U.S., 2014 39
Chart 3 12: Female Deaths, Respiratory Cancer, U.S., 2014 39
Chart 3 13: Incidence by Gender, Breast Cancer, U.S., 2014 41
Chart 3 14: Deaths by Gender, Breast Cancer, U.S., 2014 41
Chart 3 15: Male Incidence, Urinary Cancer, U.S., 2014 43
Chart 3 16: Male Deaths, Urinary Cancer, U.S., 2014 43
Chart 3 17: Female Incidence, Urinary Cancer, U.S., 2014 44
Chart 3 18: Female Deaths, Urinary Cancer, U.S., 2014 44
Chart 3 19: Male Incidence, Skin Cancer, U.S., 2014 46
Chart 3 20: Male Deaths, Skin Cancer, U.S., 2014 46
Chart 3 21: Female Incidence, Skin Cancer, U.S., 2014 47
Chart 3 22: Female Deaths, Skin Cancer, U.S., 2014 47
Chart 3 23: Male Incidence, Lymphoma Cancer, U.S., 2014 49
Chart 3 24: Male Deaths, Lymphoma Cancer, U.S., 2014 49
Chart 3 25: Female Incidence, Lymphoma Cancer, U.S., 2014 50
Chart 3 26: Female Deaths, Lymphoma Cancer, U.S., 2014 50
Chart 3 27: Male Incidence, Endocrine Cancer, U.S., 2014 52
Chart 3 28: Male Deaths, Endocrine Cancer, U.S., 2014 52
Chart 3 29: Female Incidence, Endocrine Cancer, U.S., 2014 53
Chart 3 30: Female Deaths, Endocrine Cancer, U.S., 2014 53
Chart 3 31: Male Incidence, Leukemia Cancer, U.S., 2014 55
Chart 3 32: Male Deaths, Leukemia Cancer, U.S., 2014 55
Chart 3 33: Female Incidence, Leukemia Cancer, U.S., 2014 56
Chart 3 34: Female Deaths, Leukemia Cancer, U.S., 2014 56
Chart 3 35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2014 58
Chart 3 36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2014 58
Chart 3 37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2014 59
Chart 3 38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2014 59
Chart 3 39: Incidence by Gender, Myeloma Cancer, U.S., 2014 61
Chart 3 40: Deaths by Gender, Myeloma Cancer, U.S., 2014 61
Chart 3 41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2014 63
Chart 3 42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2014 63
Chart 3 43: Incidence by Gender, Soft Tissue Cancer, U.S., 2014 65
Chart 3 44: Deaths by Gender, Soft Tissue Cancer, U.S., 2014 65
Chart 3 45: Incidence by Gender, Bone and Joint Cancers, U.S., 2014 67
Chart 3 46: Deaths by Gender, Bone and Joint Cancers, U.S., 2014 67
Chart 3 47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2014 69
Chart 3 48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2014 69
Chart 4 1: External Radiation Therapy Market by Segment, U.S., 2012 – 2022 77
Chart 4 2: External Radiation Therapy Market Breakdown, U.S., 2015 78
Chart 4 3: External Radiation Therapy Market Breakdown, U.S., 2022 78
Chart 4 4: Total External Radiation Therapy Device Market by Segment, U.S., 2012 – 2022 80
Chart 4 5: Linear Accelerator Device Market, U.S., 2012 – 2022 82
Chart 4 6: Proton Therapy Device Market, U.S., 2012 – 2022 84
Chart 4 7: Total External Radiation Therapy Device Maintenance Revenue by Segment, U.S., 2012 – 2022 86
Chart 4 8: Linear Accelerator Maintenance Revenue, U.S., 2012 – 2022 87
Chart 4 9: Proton Therapy Device Maintenance Revenue, U.S., 2012 – 2022 88
Chart 4 10: Leading Competitors, Linear Accelerator Device Market, U.S., 2015 95
Chart 4 11: Leading Competitors by Installed Base, Proton Therapy Device Market, U.S., 2015 98
Chart 5 1: Internal Radiation Therapy Device Market by Segment, U.S., 2012 – 2022 105
Chart 5 2: Internal Radiation Therapy Device Market Breakdown, U.S., 2015 106
Chart 5 3: Internal Radiation Therapy Device Market, U.S., 2022 106
Chart 5 4: Total HDR Brachytherapy Market by Segment, U.S., 2012 – 2022 108
Chart 5 5: Afterloader Market, U.S., 2012 – 2022 109
Chart 5 6: Afterloader Service Market, U.S., 2012 – 2022 110
Chart 5 7: Total LDR Brachytherapy Market by Segment, U.S., 2012 – 2022 112
Chart 5 8: Total LDR Seed Market, U.S., 2012 – 2022 114
Chart 5 9: Total LDR Seed Market by Segment, U.S., 2012 – 2022 115
Chart 5 10: Total Cesium-131 Seed Market by Segment, U.S., 2012 – 2022 117
Chart 5 11: Stranded Cesium-131 Seed Market, U.S., 2012 – 2022 118
Chart 5 12: Non-Stranded Cesium-131 Seed Market, U.S., 2012 – 2022 119
Chart 5 13: Total Paladium-103 Seed Market by Segment, U.S., 2012 – 2022 121
Chart 5 14: Stranded Paladium-103 Seed Market, U.S., 2012 – 2022 122
Chart 5 15: Non-Stranded Paladium-103 Seed Market, U.S., 2012 – 2022 123
Chart 5 16: Total Iodine-125 Seed Market by Segment, U.S., 2012 – 2022 125
Chart 5 17: Stranded Iodine-125 Seed Market, U.S., 2012 – 2022 126
Chart 5 18: Non-Stranded Iodine-125 Seed Market, U.S., 2012 – 2022 127
Chart 5 19: LDR Needle Market, U.S., 2012 – 2022 129
Chart 5 20: Leading Competitors, Internal Radiation Therapy Device Market, U.S., 2015 136
List of Figures
Figure 1 1: Interventional Oncology Device Market Share Ranking by Segment, U.S., 2015 3
Figure 1 2: Companies Research in this Report Suite, U.S., 2015 4
Figure 1 3: Factors Impacting the Interventional Oncology Device Market by Segment, U.S. 5
Figure 1 4: Recent Events in the Interventional Oncology Device Market, U.S., 2012 – 2015 (1 of 3) 6
Figure 1 5: Recent Events in the Interventional Oncology Device Market, U.S., 2012 – 2015 (2 of 3) 7
Figure 1 6: Recent Events in the Interventional Oncology Device Market, U.S., 2012 – 2015 (3 of 3) 8
Figure 1 7: Cancer Incidence Rates Covered, U.S., 2015 (1 of 2) 9
Figure 1 8: Cancer Incidence Rates Covered, U.S., 2015 (2 of 2) 10
Figure 1 9: Interventional Oncology Procedures Covered, U.S., 2015 11
Figure 1 10: Procedural Codes, U.S., 2015 12
Figure 1 11: Interventional Oncology Device Markets Covered, U.S., 2012 – 2022 (1 of 2) 13
Figure 1 12: Interventional Oncology Device Markets Covered, U.S., 2012 – 2022 (2 of 2) 14
Figure 1 13: Key Report Updates, U.S., 2016 15
Figure 1 14: Version History 15
Figure 3 1: Genital Cancer Statistics by Type and Gender, U.S., 2014 31
Figure 3 2: Digestive Cancer Statistics by Type and Gender, U.S., 2014 34
Figure 3 3: Respiratory Cancer Statistics by Type and Gender, U.S., 2014 37
Figure 3 4: Breast Cancer Statistics by Type and Gender, U.S., 2014 40
Figure 3 5: Urinary Cancer Statistics by Type and Gender, U.S., 2014 42
Figure 3 6: Skin Cancer Statistics by Type and Gender, U.S., 2014 45
Figure 3 7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2014 48
Figure 3 8: Endocrine Cancer Statistics by Type and Gender, U.S., 2014 51
Figure 3 9: Leukemia Cancer Statistics by Type and Gender, U.S., 2014 54
Figure 3 10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2014 57
Figure 3 11: Myeloma Cancer Statistics by Type and Gender, U.S., 2014 60
Figure 3 12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2014 62
Figure 3 13: Soft Tissue (Non-Heart) Cancer Statistics by Type and Gender, U.S., 2014 64
Figure 3 14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014 66
Figure 3 15: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014 68
Figure 4 1: External Radiation Therapy Market by Segment, U.S., 2012 – 2022 (US$M) 76
Figure 4 2: Total External Radiation Therapy Device Market by Segment, U.S., 2012 – 2022 (US$M) 79
Figure 4 3: Linear Accelerator Device Market, U.S., 2012 – 2022 81
Figure 4 4: Proton Therapy Device Market, U.S., 2012 – 2022 84
Figure 4 5: Total External Radiation Therapy Device Maintenance Revenue by Segment, U.S., 2012 – 2022 (US$M) 85
Figure 4 6: Linear Accelerator Maintenance Revenue, U.S., 2012 – 2022 87
Figure 4 7: Proton Therapy Device Maintenance Revenue, U.S., 2012 – 2022 88
Figure 4 8: Drivers and Limiters, Linear Accelerator Device Market, U.S., 2015 90
Figure 4 9: Drivers and Limiters, Proton Therapy Device Market, U.S., 2015 92
Figure 4 10: Leading Competitors, Linear Accelerator Device Market, U.S., 2015 94
Figure 4 11: Leading Competitors by Installed Base, Proton Therapy Device Market, U.S., 2015 98
Figure 5 1: Internal Radiation Therapy Device Market by Segment, U.S., 2012 – 2022 (US$M) 104
Figure 5 2: Total HDR Brachytherapy Market by Segment, U.S., 2012 – 2022 (US$M) 108
Figure 5 3: Afterloader Market, U.S., 2012 – 2022 109
Figure 5 4: Afterloader Service Market, U.S., 2012 – 2022 110
Figure 5 5: Total LDR Brachytherapy Market by Segment, U.S., 2012 – 2022 (US$M) 111
Figure 5 6: Total LDR Seed Market, U.S., 2012 – 2022 113
Figure 5 7: Total LDR Seed Market by Segment, U.S., 2012 – 2022 (US$M) 115
Figure 5 8: Total Cesium-131 Seed Market by Segment, U.S., 2012 – 2022 117
Figure 5 9: Stranded Cesium-131 Seed Market, U.S., 2012 – 2022 118
Figure 5 10: Non-Stranded Cesium-131 Seed Market, U.S., 2012 – 2022 119
Figure 5 11: Total Paladium-103 Seed Market by Segment, U.S., 2012 – 2022 121
Figure 5 12: Stranded Paladium-103 Seed Market, U.S., 2012 – 2022 122
Figure 5 13: Non-Stranded Paladium-103 Seed Market, U.S., 2012 – 2022 123
Figure 5 14: Total Iodine-125 Seed Market by Segment, U.S., 2012 – 2022 125
Figure 5 15: Stranded Iodine-125 Seed Market, U.S., 2012 – 2022 126
Figure 5 16: Non-Stranded Iodine-125 Seed Market, U.S., 2012 – 2022 127
Figure 5 17: LDR Needle Market, U.S., 2012 – 2022 128
Figure 5 18: Drivers and Limiters, Internal Radiation Therapy Device Market, U.S., 2015 131
Figure 5 19: Leading Competitors, Internal Radiation Therapy Device Market, U.S., 2015 135

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report